These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 27896507)
1. Levonorgestrel-Releasing Intrauterine Systems Versus Oral Cyclic Medroxyprogesterone Acetate in Endometrial Hyperplasia Therapy: A Meta-Analysis. Yuk JS; Song JY; Lee JH; Park WI; Ahn HS; Kim HJ Ann Surg Oncol; 2017 May; 24(5):1322-1329. PubMed ID: 27896507 [TBL] [Abstract][Full Text] [Related]
2. Oral and intrauterine progestogens for atypical endometrial hyperplasia. Luo L; Luo B; Zheng Y; Zhang H; Li J; Sidell N Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009458. PubMed ID: 30521671 [TBL] [Abstract][Full Text] [Related]
3. Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens. Ørbo A; Arnes M; Vereide AB; Straume B BJOG; 2016 Aug; 123(9):1512-9. PubMed ID: 26630538 [TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia. Campo G; Rebecchi A; Vanni VS; Pagliardini L; Patruno C; Papaleo E; Candiani M; Giardina P Reprod Biomed Online; 2021 Nov; 43(5):864-870. PubMed ID: 34629315 [TBL] [Abstract][Full Text] [Related]
6. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials. Abu Hashim H; Ghayaty E; El Rakhawy M Am J Obstet Gynecol; 2015 Oct; 213(4):469-78. PubMed ID: 25797236 [TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Chin J; Konje JC; Hickey M Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review. Wan YL; Holland C Climacteric; 2011 Dec; 14(6):622-32. PubMed ID: 22017273 [TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Romero SA; Young K; Hickey M; Su HI Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436 [TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Dominick S; Hickey M; Chin J; Su HI Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of different treatments based on the levonorgestrel intrauterine system in endometrial carcinoma and endometrial hyperplasia patients: a network meta-analysis. Tao M; Wu T; Zhou X; Du X; Ling K; Liang Z Arch Gynecol Obstet; 2024 Sep; 310(3):1315-1329. PubMed ID: 38980346 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study. Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693 [TBL] [Abstract][Full Text] [Related]
13. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up. Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671 [TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial. Orbo A; Vereide A; Arnes M; Pettersen I; Straume B BJOG; 2014 Mar; 121(4):477-86. PubMed ID: 24286192 [TBL] [Abstract][Full Text] [Related]
15. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691 [TBL] [Abstract][Full Text] [Related]
16. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia. Marnach ML; Butler KA; Henry MR; Hutz CE; Langstraat CL; Lohse CM; Casey PM J Womens Health (Larchmt); 2017 Apr; 26(4):368-373. PubMed ID: 27901412 [TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia. Luo L; Luo B; Zheng Y; Zhang H; Li J; Sidell N Cochrane Database Syst Rev; 2013 Jun; (6):CD009458. PubMed ID: 23737032 [TBL] [Abstract][Full Text] [Related]
18. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Ørbo A; Arnes M; Hancke C; Vereide AB; Pettersen I; Larsen K Gynecol Oncol; 2008 Oct; 111(1):68-73. PubMed ID: 18684496 [TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel-releasing intrauterine system versus systemic progestins in management of endometrial hyperplasia: A systemic review and meta-analysis. Elassall GM; Sayed EG; Abdallah NA; El-Zohiry MM; Radwan AA; AlMahdy AM; Sedik AS; Elazeem HASA; Shazly SA J Gynecol Obstet Hum Reprod; 2022 Oct; 51(8):102432. PubMed ID: 35760334 [TBL] [Abstract][Full Text] [Related]
20. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study. Kim MK; Seong SJ; Kim JW; Jeon S; Choi HS; Lee IH; Lee JH; Ju W; Song ES; Park H; Ryu HS; Lee C; Kang SB Int J Gynecol Cancer; 2016 May; 26(4):711-5. PubMed ID: 26905333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]